Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry
Holger Franken(GlaxoSmithKline (Germany)), Mikhail M. Savitski(European Molecular Biology Laboratory), Toby Mathieson, Dorothee Childs(European Molecular Biology Laboratory), Wolfgang Huber(European Molecular Biology Laboratory), Carola Doce(GlaxoSmithKline (Germany)), Thilo Werner(GlaxoSmithKline (Germany)), Marcus Bantscheff(Roche (Switzerland)), Gerard Drewes(Unknown), Friedrich Reinhard(GlaxoSmithKline (Germany)), Ina Tögel(GlaxoSmithKline (Germany)), Stephan Gade, Gavain M.A. Sweetman(GlaxoSmithKline (Germany))
Cited by 711
Related Papers
Mass-spectrometry-based draft of the human proteome
|Nature|2014|1.9k
Quantitative mass spectrometry in proteomics: a critical review
|Analytical and Bioanalytical Chemistry|2007|1.7k
Detecting differential usage of exons from RNA-seq data
|Genome Research|2012|1.6k